Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

A jury has issued a verdict to award punitive damages of $8 billion against Johnson & Johnson (J&J) relating to litigation involving Risperdal (risperidone), an antipsychotic drug used to treat certain mental/mood disorders, such as...

A roundup of developments and latest news from China (Biocad, Shanghai Pharma), India (Aurobindo, Glenmark, Lupin), and the US (Astellas). China Russia’s Biocad, Shanghai Pharma Finalize Joint Venture Biocad, a Russian pharmaceutical company,...

Janssen Sciences Ireland, part of Johnson & Johnson, has opened a new 19,100-square-meter building for biomanufacturing in Ringaskiddy, County Cork, Ireland. The company has operated a biopharmaceutical supply chain facility on its 40-hectare...

Johnson & Johnson (J&J) and its Janssen Pharmaceutical Companies have reached a settlement agreement on pending opioid litigation with the Ohio counties of Cuyahoga and Summit that resolves all of the counties’ claims and removes the...

Swedish Orphan Biovitrum (Sobi), a Stockholm, Sweden-based pharmaceutical company specializing in treatments for rare diseases, has agreed to acquire Dova Pharmaceuticals, a Durham, North Carolina-based clinical-stage biopharmaceutical company, by...

The US Food and Drug Administration (FDA) has released a suite of guidances to continue to encourage innovative approaches to the development of digital health tools and to advance the agency’s approach to overseeing these technologies along with...